Product Insight Academy: Understanding a Rebalancing Therapy Option for Hemophilia
Join us for an educational session exploring a rebalancing treatment option for hemophilia, presented by Brad Schoenfeld, Director of Advocacy and Community Engagement with Pfizer. You’ll hear:
- The science behind rebalancing therapy
- Clinical trial data
- Safety information
- Information on administration
- Shared decision-making tips for patients and caregivers
In this session, we’ll dive into a rebalancing treatment option. From how it works to clinical trial learnings, you’ll gain the latest information to help you or your loved ones understand this treatment option with confidence.
This Product Insight Academy session is hosted by Pfizer.
HFA’s Product Insight Academy is an educational program about products for patients with bleeding disorders and their caregivers, and continuing education credits are not available.
Speaker
-
Bradley SchoenfeldAdvocacy and Community Engagement Team LeadBradley Schoenfeld, Advocacy and Community Engagement Team Lead, Pfizer
Brad serves as Pfizer’s advocacy and community engagement team lead within its Rare Disease Patient Solutions organization. He brings over 15 years of experience supporting the hemophilia community, patient education and fostering connections in roles prior to joining Pfizer in 2020.
English 
Español de Puerto Rico